FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2554776677> ?p ?o ?g. }

• W2554776677 endingPage "85550" @default.
• W2554776677 startingPage "85542" @default.
• W2554776677 abstract "Erlotinib and gefitinib are weak base drugs whose absorption and clinical efficacy may be impaired by concomitant gastric acid suppressive (AS) therapy, yet proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2As) are widely indicated in non-small cell lung cancer (NSCLC) patients for the prevention and treatment of erlotinib-induced gastrointestinal injury and corticosteroid-associated gastric irritation. We assessed the clinical relevance of this potential drug-drug interaction (DDI) in a retrospective cohort of EGFR-mutant NSCLC patients.The AS usage rate was 35%. In the overall cohort, AS users did not experience poorer OS (HR: 1.47, 95% CI: 0.92 - 2.35, P = 0.10; median, 11.4 versus 17.5 months) or PFS (HR = 1.37, 95% CI: 0.89 - 2.12, P = 0.16; median, 7.6 versus 8.7 months) compared with non-users in multivariate Cox regression analysis. However, subgroup analyses indicated that AS usage was associated with significantly poorer OS and PFS in patients who had fewer or milder comorbidities (Charlson comorbidity index ≤ 2), those with Karnofsky performance status < 90, and never-smokers.A retrospective database analysis of 157 patients given erlotinib or gefitinib for EGFR-mutant advanced NSCLC from two institutions was conducted. Patients were classified as AS-users if the periods of AS and anti-EGFR therapy overlapped by ≥ 30%. Overall survival (OS) and progression-free survival (PFS) were assessed according to AS usage.Concomitant AS therapy did not have an adverse impact on OS and/or PFS in the overall cohort. Our subgroup findings should be regarded exploratory and require replication in a large prospective cohort." @default.
• W2554776677 created "2016-11-30" @default.
• W2554776677 creator A5003119794 @default.
• W2554776677 creator A5026312862 @default.
• W2554776677 creator A5032293215 @default.
• W2554776677 creator A5035392568 @default.
• W2554776677 creator A5036829075 @default.
• W2554776677 creator A5043061995 @default.
• W2554776677 creator A5077695424 @default.
• W2554776677 creator A5085404684 @default.
• W2554776677 date "2016-11-19" @default.
• W2554776677 modified "2023-10-16" @default.
• W2554776677 title "EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction" @default.
• W2554776677 cites W1548923518 @default.
• W2554776677 cites W1584673858 @default.
• W2554776677 cites W1966714873 @default.
• W2554776677 cites W1968151389 @default.
• W2554776677 cites W1971211622 @default.
• W2554776677 cites W2002056663 @default.
• W2554776677 cites W2002795751 @default.
• W2554776677 cites W2010896123 @default.
• W2554776677 cites W2018708014 @default.
• W2554776677 cites W2026603557 @default.
• W2554776677 cites W2028754167 @default.
• W2554776677 cites W2034287995 @default.
• W2554776677 cites W2043696829 @default.
• W2554776677 cites W2061817827 @default.
• W2554776677 cites W2080081537 @default.
• W2554776677 cites W2082576263 @default.
• W2554776677 cites W2084340355 @default.
• W2554776677 cites W2100116917 @default.
• W2554776677 cites W2111662961 @default.
• W2554776677 cites W2114291028 @default.
• W2554776677 cites W2129360604 @default.
• W2554776677 cites W2143555751 @default.
• W2554776677 cites W2156849452 @default.
• W2554776677 cites W2161821474 @default.
• W2554776677 cites W2162724777 @default.
• W2554776677 cites W2164844879 @default.
• W2554776677 cites W2166084034 @default.
• W2554776677 cites W2185481272 @default.
• W2554776677 cites W2258868302 @default.
• W2554776677 cites W2267994443 @default.
• W2554776677 cites W2410680960 @default.
• W2554776677 cites W4240064739 @default.
• W2554776677 doi "https://doi.org/10.18632/oncotarget.13458" @default.
• W2554776677 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5356756" @default.
• W2554776677 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27907909" @default.
• W2554776677 hasPublicationYear "2016" @default.
• W2554776677 type Work @default.
• W2554776677 sameAs 2554776677 @default.
• W2554776677 citedByCount "29" @default.
• W2554776677 countsByYear W25547766772017 @default.
• W2554776677 countsByYear W25547766772018 @default.
• W2554776677 countsByYear W25547766772019 @default.
• W2554776677 countsByYear W25547766772020 @default.
• W2554776677 countsByYear W25547766772021 @default.
• W2554776677 countsByYear W25547766772022 @default.
• W2554776677 countsByYear W25547766772023 @default.
• W2554776677 crossrefType "journal-article" @default.
• W2554776677 hasAuthorship W2554776677A5003119794 @default.
• W2554776677 hasAuthorship W2554776677A5026312862 @default.
• W2554776677 hasAuthorship W2554776677A5032293215 @default.
• W2554776677 hasAuthorship W2554776677A5035392568 @default.
• W2554776677 hasAuthorship W2554776677A5036829075 @default.
• W2554776677 hasAuthorship W2554776677A5043061995 @default.
• W2554776677 hasAuthorship W2554776677A5077695424 @default.
• W2554776677 hasAuthorship W2554776677A5085404684 @default.
• W2554776677 hasBestOaLocation W25547766771 @default.
• W2554776677 hasConcept C121608353 @default.
• W2554776677 hasConcept C126322002 @default.
• W2554776677 hasConcept C143998085 @default.
• W2554776677 hasConcept C167135981 @default.
• W2554776677 hasConcept C187960798 @default.
• W2554776677 hasConcept C207103383 @default.
• W2554776677 hasConcept C2776256026 @default.
• W2554776677 hasConcept C2778087573 @default.
• W2554776677 hasConcept C2779384505 @default.
• W2554776677 hasConcept C2779438470 @default.
• W2554776677 hasConcept C2780580887 @default.
• W2554776677 hasConcept C2909325608 @default.
• W2554776677 hasConcept C44249647 @default.
• W2554776677 hasConcept C71924100 @default.
• W2554776677 hasConcept C72563966 @default.
• W2554776677 hasConceptScore W2554776677C121608353 @default.
• W2554776677 hasConceptScore W2554776677C126322002 @default.
• W2554776677 hasConceptScore W2554776677C143998085 @default.
• W2554776677 hasConceptScore W2554776677C167135981 @default.
• W2554776677 hasConceptScore W2554776677C187960798 @default.
• W2554776677 hasConceptScore W2554776677C207103383 @default.
• W2554776677 hasConceptScore W2554776677C2776256026 @default.
• W2554776677 hasConceptScore W2554776677C2778087573 @default.
• W2554776677 hasConceptScore W2554776677C2779384505 @default.
• W2554776677 hasConceptScore W2554776677C2779438470 @default.
• W2554776677 hasConceptScore W2554776677C2780580887 @default.
• W2554776677 hasConceptScore W2554776677C2909325608 @default.
• W2554776677 hasConceptScore W2554776677C44249647 @default.
• W2554776677 hasConceptScore W2554776677C71924100 @default.

• next